Abstract
The etiology of BMS remains unknown. Role of various cytokines has
been implicated in the development of BMS. The aim of this study
was to evaluate levels of salivary IL-2 and IL-6 in patients with
BMS, compared with age-matched healthy volunteers (control group).
Whole saliva from 30 patients with BMS, age range 55–65, was
tested for the presence of IL-6 and IL-2 by enzyme immunoassay.
Control group consisted of 30 healthy participants, aged 55–65
years. Saliva IL-2 concentrations in BMS were significantly
increased in patients compared to healthy subjects: mean